BAMF
IONS icon

BI Asset Management Fondsmaeglerselskab’s Ionis Pharmaceuticals IONS Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
+25,727
New +$1.94M 0.02% 413
2026
Q1 		– Sell
-62,073
Closed -$4.91M – 648
2025
Q4 		$4.91M Buy
+62,073
New +$4.67M 0.04% 268

Other funds holding IONS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's IONS Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 25,727 shares worth $2.04M. The stake represents 0.02% of the portfolio and ranks #413 among its holdings. This is a return to the name: BI Asset Management Fondsmaeglerselskab previously reported a position in IONS as recently as Q4 2025.

BI Asset Management Fondsmaeglerselskab first reported a position in IONS in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.91M in Q4 2025. 241 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 25,727 shares of Ionis Pharmaceuticals worth $2.04M as of Q2 2026.
  • Ionis Pharmaceuticals was a new BI Asset Management Fondsmaeglerselskab position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.02% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #413 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Ionis Pharmaceuticals position peaked at $4.91M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.